171 related articles for article (PubMed ID: 25333765)
1. Probing the kinetic stabilities of Friedreich's ataxia clinical variants using a solid phase GroEL chaperonin capture platform.
Correia AR; Naik S; Fisher MT; Gomes CM
Biomolecules; 2014 Oct; 4(4):956-79. PubMed ID: 25333765
[TBL] [Abstract][Full Text] [Related]
2. Dynamics, stability and iron-binding activity of frataxin clinical mutants.
Correia AR; Pastore C; Adinolfi S; Pastore A; Gomes CM
FEBS J; 2008 Jul; 275(14):3680-90. PubMed ID: 18537827
[TBL] [Abstract][Full Text] [Related]
3. A structural approach to understanding the iron-binding properties of phylogenetically different frataxins.
Adinolfi S; Trifuoggi M; Politou AS; Martin S; Pastore A
Hum Mol Genet; 2002 Aug; 11(16):1865-77. PubMed ID: 12140189
[TBL] [Abstract][Full Text] [Related]
4. Neurodegeneration in Friedreich's ataxia: from defective frataxin to oxidative stress.
Gomes CM; Santos R
Oxid Med Cell Longev; 2013; 2013():487534. PubMed ID: 23936609
[TBL] [Abstract][Full Text] [Related]
5. Structure-function analysis of Friedreich's ataxia mutants reveals determinants of frataxin binding and activation of the Fe-S assembly complex.
Bridwell-Rabb J; Winn AM; Barondeau DP
Biochemistry; 2011 Aug; 50(33):7265-74. PubMed ID: 21776984
[TBL] [Abstract][Full Text] [Related]
6. Local energetic frustration affects the dependence of green fluorescent protein folding on the chaperonin GroEL.
Bandyopadhyay B; Goldenzweig A; Unger T; Adato O; Fleishman SJ; Unger R; Horovitz A
J Biol Chem; 2017 Dec; 292(50):20583-20591. PubMed ID: 29066625
[TBL] [Abstract][Full Text] [Related]
7. Relationship between activity and stability: Design and characterization of stable variants of human frataxin.
Castro IH; Bringas M; Doni D; Noguera ME; Capece L; Aran M; Blaustein M; Costantini P; Santos J
Arch Biochem Biophys; 2020 Sep; 691():108491. PubMed ID: 32707090
[TBL] [Abstract][Full Text] [Related]
8. Chaperonin-Based Biolayer Interferometry To Assess the Kinetic Stability of Metastable, Aggregation-Prone Proteins.
Lea WA; O'Neil PT; Machen AJ; Naik S; Chaudhri T; McGinn-Straub W; Tischer A; Auton MT; Burns JR; Baldwin MR; Khar KR; Karanicolas J; Fisher MT
Biochemistry; 2016 Sep; 55(35):4885-908. PubMed ID: 27505032
[TBL] [Abstract][Full Text] [Related]
9. Modelling Protein Plasticity: The Example of Frataxin and Its Variants.
Botticelli S; La Penna G; Nobili G; Rossi G; Stellato F; Morante S
Molecules; 2022 Mar; 27(6):. PubMed ID: 35335316
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of frataxin "bypass" in human iron-sulfur cluster biosynthesis with implications for Friedreich's ataxia.
Das D; Patra S; Bridwell-Rabb J; Barondeau DP
J Biol Chem; 2019 Jun; 294(23):9276-9284. PubMed ID: 30975898
[TBL] [Abstract][Full Text] [Related]
11. The alteration of the C-terminal region of human frataxin distorts its structural dynamics and function.
Faraj SE; Roman EA; Aran M; Gallo M; Santos J
FEBS J; 2014 Aug; 281(15):3397-419. PubMed ID: 24920569
[TBL] [Abstract][Full Text] [Related]
12. Insights on the conformational dynamics of human frataxin through modifications of loop-1.
Noguera ME; Aran M; Smal C; Vazquez DS; Herrera MG; Roman EA; Alaimo N; Gallo M; Santos J
Arch Biochem Biophys; 2017 Dec; 636():123-137. PubMed ID: 29097312
[TBL] [Abstract][Full Text] [Related]
13. Partitioning of rhodanese onto GroEL. Chaperonin binds a reversibly oxidized form derived from the native protein.
Smith KE; Voziyan PA; Fisher MT
J Biol Chem; 1998 Oct; 273(44):28677-81. PubMed ID: 9786862
[TBL] [Abstract][Full Text] [Related]
14. Proteome-wide analysis of chaperonin-dependent protein folding in Escherichia coli.
Kerner MJ; Naylor DJ; Ishihama Y; Maier T; Chang HC; Stines AP; Georgopoulos C; Frishman D; Hayer-Hartl M; Mann M; Hartl FU
Cell; 2005 Jul; 122(2):209-20. PubMed ID: 16051146
[TBL] [Abstract][Full Text] [Related]
15. Exploring the kinetic requirements for enhancement of protein folding rates in the GroEL cavity.
Betancourt MR; Thirumalai D
J Mol Biol; 1999 Apr; 287(3):627-44. PubMed ID: 10092464
[TBL] [Abstract][Full Text] [Related]
16. Kinetic model for the coupling between allosteric transitions in GroEL and substrate protein folding and aggregation.
Tehver R; Thirumalai D
J Mol Biol; 2008 Apr; 377(4):1279-95. PubMed ID: 18313071
[TBL] [Abstract][Full Text] [Related]
17. Friedreich's ataxia variants I154F and W155R diminish frataxin-based activation of the iron-sulfur cluster assembly complex.
Tsai CL; Bridwell-Rabb J; Barondeau DP
Biochemistry; 2011 Jul; 50(29):6478-87. PubMed ID: 21671584
[TBL] [Abstract][Full Text] [Related]
18. Drosophila frataxin: an iron chaperone during cellular Fe-S cluster bioassembly.
Kondapalli KC; Kok NM; Dancis A; Stemmler TL
Biochemistry; 2008 Jul; 47(26):6917-27. PubMed ID: 18540637
[TBL] [Abstract][Full Text] [Related]
19. Drug repositioning screening identifies etravirine as a potential therapeutic for friedreich's ataxia.
Alfedi G; Luffarelli R; Condò I; Pedini G; Mannucci L; Massaro DS; Benini M; Toschi N; Alaimo G; Panarello L; Pacini L; Fortuni S; Serio D; Malisan F; Testi R; Rufini A
Mov Disord; 2019 Mar; 34(3):323-334. PubMed ID: 30624801
[TBL] [Abstract][Full Text] [Related]
20. Progress towards drug discovery for Friedreich's Ataxia: Identifying synthetic oligonucleotides that more potently activate expression of human frataxin protein.
Shen X; Wong J; Prakash TP; Rigo F; Li Y; Napierala M; Corey DR
Bioorg Med Chem; 2020 Jun; 28(11):115472. PubMed ID: 32279920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
